Pillstats
Rx only · Capsule · Oral

Methsuximide

Brands: Celontin · Methsuximide

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN03AD03
RxCUI (US)47858
US makers2 labelers
Packages2
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.27$2.53$3.80$5.06Jan 2025Jun 2026Jul 2026
$4.401
Latest avg · Jul 22, 2026
+0%
Since Jan 1, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1082163234312025 Q12025 Q22025 Q32025 Q42026 Q1
321
Rx · 2026 Q1
30K
Units dispensed
-11%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Parke-Davis Div of Pfizer Incunknown1SUPPLYING
ANI Pharmaceuticals, Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.